CE Symposium - Oral Antiplatelet Therapies for Acute Coronary Syndromes and Best Practices
A CE Satellite Program taking place Thursday, May 2, 2013 at the 2013 PCNA 19th Annual Symposium from 8:00AM - 9:45AM at the Paris Las Vegas Hotel, General Session Ballroom, Las Vegas, NV.
After hospital discharge, ACS patients require efficient transitions of care to prevent the recurrence of major cardiovascular events. In addition to oral antiplatelet therapy after an ACS, a number of interventions and cardiometabolic goals (lifestyle and pharmacologic)
Register online at: http://www.pcna.net/
You must be registered for the PCNA 19th Annual Symposium in order to attend.
Thursday, May 2, 2013
Registration and Breakfast: 8:00 AM - 8:45 AM
Symposium: 8:45 AM - 9:45 AM
General Session Ballroom
Paris Las Vegas Hotel
Las Vegas, NV
Lynne T. Braun, PhD, CNP, FAHA, FPCNA, FAAN
Professor of Nursing and Nurse Practitioner
Rush University College of Nursing
Robert A. Kloner, MD, PhD
Professor of Medicine
University of Southern California
Los Angeles, California
This educational activity is provided by the Preventive Cardiovascular Nurses
Association (PCNA). Multiple educational grants have been requested to support
this program. PCNA is approved as a provider of nurse practitioner continuing
education (CE) programs by the American Association of Nurse Practitioners
(AANP), provider number 030602. This program is accredited for 1 contact hour
of continuing education. This program was planned in accordance with AANP CE
Policies and Commercial Support Standards.
Supported by an educational grant from AstraZeneca Pharmaceuticals, LP.
Registration for the PCNA 19th Annual Symposium is required in order to attend.
For additional CME activities and online cme courses visit http://www.cmeplanet.com